Innogen soars in Hong Kong debut as demand for anti-obesity drugs drive biomed bull run

Innogen soars in Hong Kong debut as demand for anti-obesity drugs drive biomed bull run

Shares of Guangzhou Innogen Pharmaceutical Group soared on their Hong Kong debut, buoyed by strong investor appetite for China’s pharmaceuticals sector, which has enjoyed rising valuations and solid performance. Trading under the stock code 2591, Innogen’s shares first changed hands at HK$72 on Friday, almost four times more than the initial public offering (IPO) price…

Read More
Alibaba raises US$5 billion from dual-currency bond issue, boosting Hong Kong’s hub status

Alibaba raises US$5 billion from dual-currency bond issue, boosting Hong Kong’s hub status

Alibaba Group Holding raised US$5 billion from a multi-tranche dual-currency bond offering, the Chinese e-commerce giant said on Wednesday, an initiative that looks to enhance Hong Kong’s role as an international financial centre. The company’s latest bond offering reflects efforts by the mainland and Hong Kong to bolster the city’s financial standing, including its function…

Read More